Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

被引:0
|
作者
Tzao, C
Nickerson, PA
Russell, JA
Gugino, SF
Steinhorn, RH
机构
[1] SUNY Buffalo, Dept Pathol, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Physiol, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA
[4] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA
关键词
nitric oxide; pulmonary hypertension; pulmonary artery; lung; nitric oxide synthase; cyclic guanosine monophosphate; soluble guanylate cyclase; animal studies;
D O I
10.1002/1099-0496(200102)31:2<97::AID-PPUL1016>3.0.CO;2-K
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The nitric oxide (NO)-guanosine 3',5'-cyclic monophosphate (cGMP) signaling pathway plays an important role in the pulmonary vascular transition at birth. We studied pulmonary arteries and veins isolated from normal late-gestation fetal lambs and from fetal lambs with persistent pulmonary hypertension (PPHN) following prenatal ligation of the ductus arteriosus. We additionally used double immunolabeling and immunoblot analysis to determine relative vascular contents of endothelial nitric oxide synthase (NOS-III) and soluble guanylate cyclase (sGC). Cyclic GMP content and sGC activity were significantly lower in arteries from hypertensive lambs than controls. A rank order for contents of both soluble guanylate cyclase and NOS-III was observed by both immunolabeling and immunoblotting: Control vein = Hypertensive vein > Control artery > Hypertensive artery. Our data demonstrate that the relative expression of sGC correlates well with the relative expression of NOS-III, and indicate the potential importance of soluble guanylate cyclase in the regulation of the perinatal pulmonary circulation. These data may help us understand vascular mechanisms producing PPHN, as well as patterns of response to exogenous NO. Pediatr Pulmonol. 2001; 31:97-105, (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [21] Localization of soluble guanylate cyclase (sGC) in pulmonary vasculature of fetal sheep.
    DAngelis, C
    Tzao, A
    Morin, FC
    Wild, LM
    Steinhorn, RH
    Nickerson, PA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1960 - 1960
  • [22] Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling
    Dumitrascu, R
    Weissmann, N
    Ghofrani, HA
    Dony, E
    Beuerlein, K
    Schmidt, H
    Stasch, JP
    Gnoth, MJ
    Seeger, W
    Grimminger, F
    Schermuly, RT
    CIRCULATION, 2006, 113 (02) : 286 - 295
  • [23] Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis
    Zagorski, John
    Neto-Neves, Evandro
    Alves, Nathan J.
    Fisher, Amanda J.
    Kline, Jeffrey A.
    PHYSIOLOGICAL REPORTS, 2022, 10 (01):
  • [24] Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension
    Shaul, PW
    Yuhanna, IS
    German, Z
    Chen, Z
    Steinhorn, RH
    Morin, FC
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (05) : L1005 - L1012
  • [25] Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn
    Lakshminrusimha, Satyan
    Porta, Nicolas F. M.
    Farrow, Kathryn N.
    Chen, Bernadette
    Gugino, Sylvia F.
    Kumar, Vasanth H.
    Russell, James A.
    Steinhorn, Robin H.
    PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (01) : 106 - 112
  • [26] Effects of a Soluble Guanylate Cyclase Stimulator Riociguat on Contractility of Isolated Pulmonary Artery and Hemodynamics of U46619-Induced Pulmonary Hypertension in Dogs
    Kameshima, Satoshi
    Nakamura, Yuki
    Uehara, Kenji
    Kodama, Tomoko
    Yamawaki, Hideyuki
    Nishi, Kotaro
    Okano, Shozo
    Niijima, Ryo
    Kimura, Yuya
    Itoh, Naoyuki
    VETERINARY SCIENCES, 2023, 10 (02)
  • [27] First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
    Grimminger, F.
    Weimann, G.
    Frey, R.
    Voswinckel, R.
    Thamm, M.
    Boelkow, D.
    Weissmann, N.
    Mueck, W.
    Unger, S.
    Wensing, G.
    Schermuly, R. T.
    Ghofrani, H. A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (04) : 785 - 792
  • [28] A Phase 2 Study of the Soluble Guanylate Cyclase Stimulator Riociguat in Patients with Chronic Thromboembolic Pulmonary Hypertension or Pulmonary Arterial Hypertension
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    Halank, Michael
    Meyer, F. Joachim
    Staehler, Gerd
    Behr, Juergen
    Ewert, Ralf
    Weimann, Gerrit
    Grimminger, Friedrich
    CIRCULATION, 2010, 122 (02) : E239 - E239
  • [29] Pharmacological effects of a new soluble guanylate cyclase stimulator in experimental pulmonary arterial hypertension
    Bykov, V. V.
    Bykova, A., V
    Stankevich, S. A.
    Aliev, O., I
    Sidekhmenova, A., V
    Dunaeva, O., I
    Khazanov, V. A.
    Vengerovskii, A., I
    Udut, V. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2023, 22 (01): : 14 - 22
  • [30] Angiotensin II increases soluble guanylate cyclase protein levels in bovine pulmonary arteries.
    Burke-Wolin, TM
    Sergi, MA
    Maki, J
    Olson, SC
    CIRCULATION, 1998, 98 (17) : 342 - 342